Search Results - "ALTON, Kevin B"
-
1
Intestinal lymphatic transport for drug delivery
Published in Advanced drug delivery reviews (10-09-2011)“…Intestinal lymphatic transport has been shown to be an absorptive pathway following oral administration of lipids and an increasing number of lipophilic drugs,…”
Get full text
Journal Article -
2
Application of mass spectrometry for metabolite identification
Published in Current drug metabolism (01-07-2006)“…Metabolism studies play a pivotal role in drug discovery and development. Characterization of metabolic "hot-spots" as well as reactive and pharmacologically…”
Get more information
Journal Article -
3
Characterization of Human Liver Enzymes Involved in the Biotransformation of Boceprevir, a Hepatitis C Virus Protease Inhibitor
Published in Drug metabolism and disposition (01-03-2011)“…Boceprevir (SCH 503034), a protease inhibitor, is under clinical development for the treatment of human hepatitis C virus infections. In human liver…”
Get full text
Journal Article -
4
Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663
Published in British journal of pharmacology (01-04-2000)“…Previous studies described the metabolism‐based discovery of a potent, selective inhibitor of intestinal absorption of cholesterol, SCH58235 (Ezetimibe). Here…”
Get full text
Journal Article -
5
Disposition of the Selective Cholesterol Absorption Inhibitor Ezetimibe in Healthy Male Subjects
Published in Drug metabolism and disposition (01-04-2002)“…Ezetimibe [SCH 58235; 1-(4-fluorophenyl)-3( R )-[3-(4-fluorophenyl)-3( S )-hydroxypropyl]-4( S )-(4-hydroxyphenyl)-2-azetidinone], a selective cholesterol…”
Get full text
Journal Article -
6
CCD photometry, Roche modelling and period analysis of the W UMa eclipsing binary star system AR CrB
Published in Monthly notices of the Royal Astronomical Society (21-09-2018)Get full text
Journal Article -
7
Identification of Human Liver Cytochrome P450 Enzymes Involved in Biotransformation of Vicriviroc, a CCR5 Receptor Antagonist
Published in Drug metabolism and disposition (01-12-2007)“…Vicriviroc (SCH 417690), a CCR5 receptor antagonist, is currently under investigation for the treatment of human immunodeficiency virus infection. The…”
Get full text
Journal Article -
8
The Rise and Fall of the King: The Correlation between FO Aquarii's Low States and the White Dwarf's Spin-down
Published in The Astrophysical journal (01-06-2020)“…The intermediate polar FO Aquarii (FO Aqr) experienced its first reported low-accretion states in 2016, 2017, and 2018, and, using newly available photographic…”
Get full text
Journal Article -
9
A comprehensive investigation of the variable overcontact system EH Cancri
Published in Journal of astrophysics and astronomy (01-12-2020)“…Precise multi-color CCD-derived photometric data were obtained from EH Cnc at two sites during 2010, 2014 and 2018 wherein each epoch used a different…”
Get full text
Journal Article -
10
Ezetimibe : A review of its metabolism, pharmacokinetics and drug interactions
Published in Clinical pharmacokinetics (01-01-2005)“…Ezetimibe is the first lipid-lowering drug that inhibits intestinal uptake of dietary and biliary cholesterol without affecting the absorption of fat-soluble…”
Get full text
Journal Article -
11
Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: Investigation of nicotinic acid receptor agonists
Published in Toxicology and applied pharmacology (15-08-2011)“…An investigative renal toxicity study using metabolomics was conducted with a potent nicotinic acid receptor (NAR) agonist, SCH 900424. Liquid…”
Get full text
Journal Article -
12
Identification of Human Liver Cytochrome P450 Enzymes Involved in the Metabolism of SCH 530348 (Vorapaxar), a Potent Oral Thrombin Protease-Activated Receptor 1 Antagonist
Published in Drug metabolism and disposition (2011)“…Vorapaxar (SCH 530348), a potent oral thrombin protease-activated receptor 1 antagonist, is being developed as an antiplatelet agent for patients with…”
Get full text
Journal Article -
13
Response Normalized Liquid Chromatography Nanospray Ionization Mass Spectrometry
Published in Journal of the American Society for Mass Spectrometry (01-10-2007)“…The widely different LC-MS response observed for many structurally different compounds limits the use of LC-MS in full scan detection mode for quantitative…”
Get full text
Journal Article -
14
Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of 3-hydroxydesloratadine
Published in Biopharmaceutics & drug disposition (01-09-2004)“…Desloratadine is a non‐sedating antihistamine recently approved for the treatment of seasonal allergic rhinitis. The major metabolite of desloratadine in human…”
Get full text
Journal Article -
15
Quantitation of Parent Drug and Its Unstable Metabolites by in Situ Coulometric Oxidation and Liquid Chromatography−Tandem Mass Spectrometry
Published in Analytical chemistry (Washington) (15-12-2010)“…Recent FDA and ICH guidances on safety testing of drug metabolites have challenged the way we traditionally think about quantitative bioanalytical methods…”
Get full text
Journal Article -
16
Identification of Two Novel Metabolites of SCH 486757, a Nociceptin/Orphanin FQ Peptide Receptor Agonist, in Humans
Published in Drug metabolism and disposition (01-11-2010)“…The study of human metabolism of endo-8[bis(2-chlorophenyl)methyl]-3-(2-pyrimidinyl)-8-azabicyclo[3.2.1]octan-3-ol (SCH 486757) after a 200-mg oral dose of the…”
Get full text
Journal Article -
17
Thermally Induced N-to-O Rearrangement of tert-N-Oxides in Atmospheric Pressure Chemical Ionization and Atmospheric Pressure Photoionization Mass Spectrometry: Differentiation of N-Oxidation from Hydroxylation and Potential Determination of N-Oxidation Site
Published in Analytical chemistry (Washington) (01-06-2005)“…N-Oxides are known to undergo deoxygenation during atmospheric pressure chemical ionization (Ramanathan, R.; Su, A.-D.; Alvarez, N.; Blumenkrantz, N.;…”
Get full text
Journal Article -
18
In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461
Published in The Journal of pharmacology and experimental therapeutics (01-10-1997)“…SCH48461 is a selective and highly potent inhibitor of cholesterol absorption. In rats, SCH48461 is rapidly and completely metabolized in the first pass…”
Get more information
Journal Article -
19
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs
Published in Metabolism, clinical and experimental (01-10-2001)“…Ezetimibe (SCH 58235) and SCH 48461 are potent cholesterol absorption inhibitors, which cause significant decreases in plasma cholesterol levels in…”
Get full text
Journal Article -
20
Identification of unstable metabolites of Lonafarnib using liquid chromatography-quadrupole time-of-flight mass spectrometry, stable isotope incorporation and ion source temperature alteration
Published in Journal of mass spectrometry. (01-11-2006)“…Structural characterization of unstable metabolites and other drug‐derived entities poses a serious challenge to the analytical chemist using instrumentation…”
Get full text
Journal Article